Evaluation of injection-site-related adverse events with galcanezumab: a post hoc analysis of phase 3 studies in participants with migraine - Stauffer, VL; Wang, S; Bonner, J; Kim, B; Bhandari, R; Day, KA (BMC Neurol, 2020)